Stress-induced relapse to heroin and cocaine seeking in rats: A review

Brain Research Reviews

Volumn 33, Issue 1, 2000, Pages 13-33

  Shaham, Yavin ^a   Erb, Suzanne ^b   Stewart, Jane ^b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b Kinesiology and Applied Physiology Center for Studies in Behavioral Neurobiology   (Canada)

Author keywords

Cocaine; Heroin; Reinstatement; Relapse; Review; Stress

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CLONIDINE; COCAINE; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; DIAMORPHINE; FLUPENTIXOL DECANOATE; GUANABENZ; LOFEXIDINE; METYRAPONE; NALTREXONE; RACLOPRIDE;

AMYGDALOID NUCLEUS; COCAINE DEPENDENCE; DRUG ABUSE; HEROIN DEPENDENCE; LOCUS CERULEUS; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RELAPSE; REVIEW; SHOCK; STRESS; STRIA TERMINALIS;

ANIMALS; COCAINE-RELATED DISORDERS; HEROIN DEPENDENCE; HUMANS; RATS; RECURRENCE; STRESS;

EID: 0033850835     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(00)00024-2     Document Type: Review

References (222)

1. G.K. Aghajanian, CP. VanderMaelen, Alpha 2-adrenoceptor-me-diated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo, Science 215 (1982) 1394-1396.
2. S.H. Ahmed, G.F. Koob, Cocaine-but not food-seeking behavior is reinstated by stress after extinction, Psychopharmacology 32 (1997) 289-295.
3. S.H. Ahmed, J.R. Walker, G.F. Koob, Persistent increase in the motivation to take heroin in rats with history of drug escalation, Neuropsychopharmacology 22 (2000) 413-421.
4. H. Akil, J. Madden, R.L. Patrick, J.D. Barchas, Stress-induced increase in endogenous opiate peptides: concurrent analgesia and its partial reversal by naloxone, in: H.W. Kosterlitz (Ed.), Opiates and Endogenous Opioid Peptides, Amsterdam, 1976, pp. 63-70.
5. G.F. Alheid, C.A. Beltramino, J.S. De Olmos, M.S. Forbes, D.J. Swanson, L. Heimer, The neuronal organization of the supracapsular part of the stria terminalis in the rat: the dorsal component of the extended amygdala, Neuroscience 84 (1998) 967-996.
6. Z. Amit, H. Galina, Stress-induced analgesia: adaptive pain suppression, Physiol. Rev. 66 (1986) 1091-1120.
7. G. Aston-Jones, J.M. Delfs, J. Druhan, Y. Zhu, The bed nucleus of the stria terminalis: a target site for noradrenergic actions in opiate withdrawal, Ann. NY Acad. Sci. 877 (1999) 486-498.
8. G. Aston-Jones, M.T. Shipley, R. Grzanna, The locus coeruleus, A5 and A7 noradrenergic cell groups, in: G. Paxinos (Ed.), The Rat Nervous System, Academic Press, San Diego, CA, 1995, pp. 183213.
9. A. Badiani, M.M. Oates, H.E. Day, S.J. Watson, H. Akil, T.E. Robinson, Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty, J. Neurosci. 18 (1998) 10579-10593.
10. H.N. Bhargava, Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome and self-administration behavior, Pharmacol. Rev. 46 (1994) 293-324.
11. B. Borowsky, C.M. Kuhn, Chronic cocaine administration sensitizes behavioral but not neuroendocrine responses, Brain Res. 543 (1991) 301-306.
12. M.E. Bouton, R.C. Bolles, Contextual control of the extinction of conditioned fear, Learn. Motiv. 10 (1979) 445-466.
13. M.E. Bouton, D.A. King, Contextual control of the extinction of conditioned fear: tests for the associative value of the context, J. Exp. Psychol.: Anim. Behav. Processes 9 (1983) 248-265.
14. M.E. Bouton, D. Swartzentruber, Sources of relapse after extinction in Pavlovian and instrumental learning, Clin. Psychol. Rev. 11 (1991) 123-140.
15. J.D. Bremner, J.H. Krystal, S.M. Southwick, D.S. Charney, Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies, Synapse 23 (1996) 28-38.
16. J.D. Bremner, J.H. Krystal, S.M. Southwick, D.S. Charney, Noradrenergic mechanisms in stress and anxiety: II. Clinical studies, Synapse 23 (1996) 39-51.
17. C.J. Brimer, Disinhibition of operant response, Learn. Motiv. 1 (1970) 346-371.
18. J.S. Brog, A. Salyapongse, A.Y. Deutch, D.S. Zahm, The patterns of afferent innervation of the core and shell in the 'accumbens' part of the rat ventral striatum: immunohistochemical detection of retrog-radely transported fluoro-gold, J. Comp. Neurol. 338 (1993) 255278.
19. S.A. Brown, P.W. Vik, T.L. Patterson, I. Grant, M.A. Schuckit, Stress, vulnerability and adult alcohol relapse, J. Stud. Alcohol 56 (1995) 538-545.
20. G. Brozek, I.A. Zhuravin, D. Megirian, J. Bures, Localization of the central rhythm generator involved in spontaneous consummatory licking in rats: functional ablation and electrical brain stimulation studies, Proc. Natl. Acad. Sci USA 93 (1996) 3325-3329.
21. J. Buckingham, T. Cooper, Differences in hypothalamic-pituitary- adrenocortical activity in the rat after acute and prolonged treatment with morphine, Neuroendocrinology 38 (1984) 411-417.
22. Y. Buczek, A.D. Lê, S. Leung, J. Watchus, J. Stewart, Y. Shaham, Studies on the generality of the effect of stress on relapse to drug seeking, Soc. Neurosci. Abstr. 24 (1998) 498.
23. Y. Buczek, A.D. Lê, A. Wang, J. Stewart, Y. Shaham, Stress reinstates nicotine seeking but not sucrose solution seeking in rats, Psychopharmacology 144 (1999) 183-188.
24. S. Cabeza de Vaca, K.D. Carr, Food restriction enhances the central rewarding effect of abused drugs, J. Neurosci. 18 (1998) 75027510.
25. S. Cabib, A. Imperato, Stress, depression and the mesolimbic dopamine system, Psychopharamacology 128 (1996) 331-342.
26. U.C. Campbell, S.T.C.M.E. Lac, Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats, Psychopharamacology 143 (1999) 209-214.
27. W.A. Carlezon, R.A. Wise, Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex, J. Neurosci. 16 (1996) 3112-3122.
28. M.E. Carroll, The role of food deprivation in the maintenance and reinstatement of cocaine-seeking behavior in rats, Drug Alcohol Dependence 16 (1985) 95-109.
29. M.E. Carroll, S.D. Comer, Animal models of relapse, Exp. Clin. Psychopharmacol. 4 (1996) 11-18.
30. M.E. Carroll, M.E. Meisch, Increased drug-reinforced behavior due to food deprivation, in: T. Thompson, P.B. Dews, J.E. Barrett (Eds.), Advances in Behavioral Pharmacology, Academic Press, New York, 1984, pp. 47-88.
31. A.J. Carter, Hippocampal noradrenaline release in awake, freely moving rats is regulated by alpha-2 adrenoceptors but not by adenosine receptors, J. Pharmacol. Exp. Ther. 281 (1997) 648-654.
32. B.L. Carter, S.T. Tiffany, Meta-analysis of cue-reactivity in addiction research, Addiction 94 (1999) 327-340.
33. C.A. Catania, in: Learning, 3rd Edition, Prentice-Hall, Englewood Cliffs, NJ, 1992.
34. D.T. Chalmers, T.W. Lovenberg, E.B. de Souza, Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression, J. Neurosci. 15 (1995) 63406350.
35. J.S. Chen, A. Amsel, Prolonged, unsignalled inescapable shocks increase persistence in subsequent appetitive and instrumental tasks, Anim. Learn. Behav. 5 (1977) 377-385.
36. A.R. Childress, R. Ehrman, D.J. Rohsenow, S.J. Robbins, C.P. O'Brien, Classically conditioned factors in drug dependence, in: J.W. Lowinson, P. Luiz, R.B. Millman, G. Langard (Eds.), Substance Abuse: A Comprehensive Textbook, Williams and Wilkins, Baltimore, MD, 1992, pp. 56-69.
37. A.R. Childress, R. Ehrman, A.T. McLellan, J. MacRae, M. Natale, C.P. O'Brien, Can induced moods trigger drugrelated responses in opiate abuse patients?, J. Subst. Abuse Treat. 11 (1994) 17-23.
38. B.J. Cole, T.W. Robbins, Dissociable effects of lesions to the dorsal or ventral noradrenergic bundle on the acquisition, performance, and extinction of aversive conditioning, Behav. Neurosci. 101 (1987) 476-488.
39. J.R. Cooper, F.E. Bloom, R.H. Roth, in: The Biochemical Basis of Neuropharmacology, 5th Edition, Oxford University Press, New York, 1986.
40. M.L. Cooper, M. Russell, J.B. Skinner, M.R. Frone, P. Mudar, Stress and alcohol use: moderating effects of gender, coping and alcohol expectancies, J. Abnorm. Psychol. 101 (1992) 139-152.
41. W.M. Davis, S.G. Smith, Role of conditioned reinforcers in the initiation, maintenance and extinction of drug-seeking behavior, Pavlovian J. Biol. Sci. 11 (1976) 222-236.
42. M. Davis, D.L. Walker, Y. Lee, Roles of the amygdala and bed nucleus of the stria terminalis in fear and anxiety measured with the acoustic startle reflex. Possible relevance to PTSD, Ann. NY Acad. Sci. 821 (1997) 305-331.
43. E.B. de Souza, Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders, Psychoneuroendocrinology 20 (1995) 789-819.
44. T.J. De Vries, A.N. Schoffelmeer, R. Binnekade, L.J. Vanderschuren, Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration, Psychopharamacology 143 (1999) 254-260.
45. H. de Wit, Priming effects with drugs and other reinforcers, Exp. Clin. Psychopharmacol. 4 (1996) 5-10.
46. H. de Wit, J. Stewart, Reinstatement of cocaine-reinforced responding in the rat, Psychopharmacology 75 (1981) 134-143.
47. J.M. Delfs, Y. Zhou, J.P. Druhan, G. Aston-Jones, Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat, Brain Res. 806 (1998) 127-140.
48. J.M. Delfs, J.P. Zhu, J. Druhan, G. Aston-Jones, Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion, Nature 403 (2000) 430-434.
49. V. Deroche, M. Marinelli, M. Le Moal, P.V. Piazza, Glucocorticoids and behavioral effects of psychostimulants II: cocaine intravenous self-administration and reinstatement depend on glucocorticoids levels, J. Pharmcol. Exp. Ther. 281 (1997) 1401-1407.
50. V. Deroche, M. Le Moal, P.V. Piazza, Cocaine self-administration increases the incentive motivational properties of the drug in rats, Eur. J. Neurosci. 11 (1999) 2731-2736.
51. J.A. Deutch, C.I. Howarth, Evocation by fear of a habit learned for electrical stimulation of the brain, Science 130 (1962) 1057-1058.
52. A.Y. Deutch, R.H. Roth, The determinants of stress-induced activation of the prefrontal cortical dopamine system, Prog. Brain Res. 85 (1990) 367-403.
53. L.D. Devenport, S. Balagura, Lateral hypothalamus: reevaluation of function in motivated feeding behavior, Science 172 (1972) 744746.
54. A.J. Dunn, C.M. Berridge, Physiological and behavioral responses to corticotropin-releasing factor: is CRF a mediator of anxiety or stress responses?, Brain Res. Rev. 15 (1990) 71-100.
55. S. Erb, Y. Shaham, J. Stewart, Stress reinstates cocaine-seeking behavior after prolonged extinction and drug-free periods, Psychopharmacology 128 (1996) 408-412.
56. S. Erb, J. Stewart, A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking, J. Neurosci. RC35 (1999) 1-6.
57. 2-Adrenergic agonists block stress-induced reinstatement of cocaine seeking, Neuropsychopharmacology (2000) in press.
58. S. Erb, Y. Shaham, J. Stewart, The role of corticotropin-releasing factor and corticosterone in stressand cocaine-induced relapse to cocaine seeking in rats, J. Neurosci. 14 (1998) 5529-5536.
59. A. Ettenberg, L.A. MacConell, T.D. Geist, Effect of haloperidol in a response-reinstatement model of heroin relapse, Psychopharmacology 124 (1996) 205-210.
60. B.J. Everitt, J.A. Parkinson, M.C. Olmstead, M. Arroyo, P. Robledo, T.W. Robbins, Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems, Ann. NY Acad. Sci. 877 (1999) 412-438.
61. J.M. Fahey, G.A. Pritchard, L.L. Moltke, J.S. Pratt, J.M. Grassi, R.I. Shader, D.J. Greenblatt, Effects of ketoconazole on triazolam pharmacokinetics, pharmacodynamics and benzodiazepine receptor binding in mice, J. Pharmacol. Exp. Ther. 285 (1998) 271-276.
62. J. Feldon, J.A. Gray, The partial reinforcement extinction effect: Influence of clordiazepoxide in septal lesioned rats, Psycho-pharamacology 74 (1979) 280-289.
63. S.L. Foote, F.E. Bloom, G. Aston-Jones, Nucleus locus coeruleus: new evidence of anatomical and physiological specificity, Physiol. Rev. 63 (1983) 844-914.
64. J.M. Fritschy, R. Grzanna, Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?, Prog. Brain Res. 88 (1991) 257-268.
65. S. Garcia Belenguer, C. Oliver, P. Mormede, Facilitation and feedback in the hypothalamo-pituitary-adrenal axis during food restriction in rats, J. Neuroendocrinol. 5 (1993) 663-668.
66. E.L. Gardner, Brain reward mechanisms, in: J.W. Lowinson, P. Luiz, R.B. Millman, G. Langard (Eds.), Substance Abuse: A Comprehensive Textbook, Williams & Wilkins, Baltimore, MD, 1992, pp. 70-99.
67. G.J. Gerber, R. Stretch, Drug-induced reinstatement of extinguished self-administration behavior in monkeys, Pharmacol. Biochem. Behav. 3 (1975) 1055-1061.
68. K. Gietzen, L. Penka, R. Eisenburger, Imidazole fungicides provoke histamine release from mast cells and induce airway contraction, Exp. Toxicol. Pathol. 48 (1996) 529-531.
69. J.R. Glowa, J.E. Barrett, P.W. Gold, Effects ofcorticotropin releasing hormone on appetitive behaviors, Peptides 13 (1992) 609-621.
70. A. Gobert, J.M. Rivet, V. Audinot, A. Newman-Tancredi, L. Cistarelli, M.J. Millan, Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto-and heteroreceptor-mediated control of release, Neuroscience 84 (1998) 413-429.
71. N.E. Goeders, A neuroendocrine role in cocaine reinforcement, Psychoneuroendocrinology 22 (1997) 237-259.
72. A. Goldstein, A. Naidu, Multiple opioid receptors: ligand selectivity profiles and binding sites signatures, Mol. Pharmacol. 36 (1989) 265-272.
73. E.E. Gorenstein, J.P. Newman, Disinhibitory psychopathology: A new perspective and a model for research, Psychol. Rev. 87 (1980) 301-315.
74. J.A. Gray, in: The Psychology of Fear and Stress, 2nd Edition, Cambridge University Press, New York, 1987.
75. J.A. Gray, N. McNaughton, Comparison between the behavioural effects of septal and hippocampal lesions: a review, Neurosci. Biobehav. Rev. 7 (1983) 119-188.
76. S.P. Grossman, An experimental 'dissection' of the septal syndrome, Ciba Found. Symp. 58 (1977) 227-273.
77. C. Guaza, A. Torrellas, S. Borrell, Adrenocortical response to acute and chronic ethanol administration in rats, Psychopharamacology 79 (1983) 173-176.
78. S.M. Hall, B.E. Havassy, D.A. Wassermann, Commitment to abstinence and acute stress in relapse to alcohol, opiates and nicotine, J. Consult. Clin. Psychol. 58 (1990) 175-181.
79. S. Hansen, E.J. Stanfield, B.J. Everitt, The role of ventral bundle noradrenergic neurones in sensory components of sexual behaviour and coitus-induced pseudopregnancy, Nature 286 (1980) 152-154.
80. R.E. Harlan, B.D. Shivers, L. Kow, D.W. Pfaff, Estrogenic maintenance of lordotic responsiveness: requirement for hypothalamic action potentials, Brain Res. 268 (1983) 67-78.
81. W.R. Heckman, B.R. Kane, R.E. Pakyz, M.J. Cosentino, The effect of ketoconazole on endocrine and reproductive parameters in male mice and rats, J. Androl. 13 (1992) 191-198.
82. L. Heimer, R.E. Harlan, G.F. Alheid, M.M. Garcia, J. De Olmos, Substantia innominata: a notion which impedes clinical-anatomical correlations in neuropsychiatric disorders, Neuroscience 76 (1997) 957-1006.
83. S.C. Heinrichs, F. Menzaghi, G. Schulteis, G.F. Koob, L. Stinus, Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal, Behav. Pharmacol. 6 (1995) 74-80.
84. B.H. Herman, C.P. O'Brien, Clinical medications development for opiate addiction: focus on nonopioid and opioid antagonists for the amelioration of opiate withdrawal symptoms and relapse prevention, Semin. Neurosci. 9 (1997) 158-172.
85. D. Highfield, A. Clements, U. Shalev, R.J. McDonald, R. Feather-stone, J. Stewart, Y. Shaham, Involvement of the medial septum in stress-induced relapse to heroin seeking in rats, Eur. J. Neurosci. 12 (2000) 705-713.
86. C.K. Himmelsbach, Studies on the relation of drug addiction to the autonomic nervous system: results of cold pressor tests, J. Pharmacol. Exp. Ther. 73 (1941) 91-98.
87. C.K. Himmelsbach, Clinical studies of drug addiction, Arch. Int. Med. 69 (1942) 766-775.
88. M.R. Holahan, N.H. Kalin, A.E. Kelley, Microinfusion of corticot-ropin-releasing factor into the nucleus accumbens shell results in increased behavioral arousal and oral motor activity, Psycho-pharmacology 130 (1997) 189-196.
89. T. Holdstock, Effects of septal stimulation in rats on heart rate and galvanic skin response, Psychonom. Sci. 9 (1967) 38.
90. P. Hornby, D. Piekut, Opiocortin and catecholamine input to CRF-immunoreactive neurons in rat forebrain, Peptides 10 (1989) 1139-1146.
91. S. Ikemoto, J. Panksepp, The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking, Brain Res. Rev. 31 (1999) 6-41.
92. J.H. Jaffe, Drug addiction and drug abuse, in: A.G. Gilman, T.W. Rall, A.S. Nies, P. Taylor (Eds.), Goodman & Gilman's The Pharmacological Basis of Therapeutics, Pergamon, New York, 1990, pp. 522-573.
93. J.H. Jaffe, N.G. Cascell, K.M. Kumor, M.A. Sherer, Cocaineinduced cocaine craving, Psychopharmacology 97 (1989) 59-64.
94. R.L. Jakab, C. Leranth, The septum, in: G. Paxinos (Ed.), The Rat Nervous System, Academic Press, San Diego, CA, 1996, pp. 405-442.
95. J. Jenkins, J. Meakin, D. Nelson, G. Thorn, Inhibition of adrenal steroid 11 oxygenation in the dog, Science 128 (1958) 478-480.
96. J.D. Jentsch, J.R. Taylor, Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli, Psychopharamacology 146 (1999) 373-390.
97. E.O. Johnson, T.C. Kamilaris, G.P. Chrousos, P.W. Gold, Mechanisms of stress: a dynamic overview of hormonal and behavioral homeostasis, Neurosci. Biobehav. Rev. 16 (1992) 115-130.
98. G. Ju, L.W. Swanson, R.B. Simerly, Studies on the cellular architecture of the bed nuclei of the stria terminalis in the rat: II. Chemoarchitecture, J. Comp. Neurol. 280 (1989) 603-621.
99. P.W. Kalivas, J. Stewart, Dopamine transmission in the initiation and expression of drugand stress-induced sensitization of motor activity, Brain Res. Rev. 16 (1991) 223-244.
100. G.J. Kant, T. Eggleston, L. Landman-Rorbers, C.C. Kenion, G.C. Driver, J.L. Meyerhoff, Habituation to repeated stress is stressor specific, Pharmacol. Biochem. Behav. 22 (1985) 631-634.
101. S.N. Katner, J.G. Magalong, F. Weiss, Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat, Neuropsychopharmacology 20 (1999) 471-479.
102. A.E. Kelley, Functional specificity of ventral striatal compartments in appetitive behaviors, Ann. NY Acad. Sci. 877 (1999) 71-90.
103. F.A. King, P.M. Meyer, Effects of amygdaloid lesions upon septal hyper-emotionality in the rats, Science 128 (1958) 655-656.
104. F.B. Kleiner, P.M. Meyer, D.R. Meyer, Effects of simultaneous septal and amygdala upon emotionality and retention of a black-white discrimination, Brain Res. 5 (1967) 459-468.
105. G.F. Koob, F.E. Bloom, Cellular and molecular mechanisms of drug dependence, Science 242 (1988) 715-723.
106. T.R. Kosten, B.J. Rounsaville, H.D. Kleber, A 2.5-year follow-up of depressions, life crises, and treatment effects on abstinence among opioid addicts, Arch. Gen. Psychiatry 43 (1986) 733-739.
107. D.D. Krahn, B.A. Gosnell, A.S. Levine, J.E. Morley, Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects, Brain Res. 443 (1988) 63-69.
108. M.J. Kreek, G.F. Koob, Drug dependence: stress and dysregulation of brain reward systems, Drug Alcohol Depend. 51 (1998) 23-47.
109. S.R. Laviolette, D. Van der Kooy, Opiate dependence and withdrawal alters the motivational properties of GABA-A receptor function in the ventral tegmental area, Soc. Neurosci. Abstr. 25 (1999) 1375.
110. Y. Lee, M. Davis, Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex, J. Neurosci. 17 (1997) 6434-6446.
111. Y. Lee, M. Davis, Role of the septum in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex, J. Neurosci. 17 (1997) 6424-6433.
112. A.D. Le, B. Quan, W. Juzystch, P.J. Fletcher, N. Joharchi, Y. Shaham, Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats, Psychopharmacology 135 (1998) 169-174.
113. A.D. Le, C.X. Poulos, S. Harding, W. Watchus, W. Juzytsch, Y. Shaham, Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress in rats, Neuropsychopharmacology 21 (1999) 435-444.
114. A.D. Le, S. Harding, W. Juzytsch, Y. Shaham, The role of corticotropin-releasing factor in stress-induced relapse to alcohol seeking, Psychopharmacology (2000) in press.
115. S.K. Lin, J. Strang, L.W. Su, C.J. Tsai, W.H. Hu, Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal, Drug Alcohol Depend. 48 (1997) 127-133.
116. M.V. Linnoila, M. Virkkunen, Aggression, suicidality, and serotonin, J. Clin. Psychiatry 53 (Suppl.) (1992) 46-51.
117. D.S. Loose, E.P. Stover, D. Feldman, Ketoconazole binds to glucocorticoid receptors and exhibits glucocorticoid antagonist activity in cultured cells, J. Clin. Invest. 72 (1983) 404-408.
118. J. Lundkvist, Z. Chai, R. Teheranian, H. Hasanvan, T. Bartfai, F. Jenck, U. Widmer, J.L. Moreau, A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like effects, Eur. J. Pharmacol. 309 (1996) 195-200.
119. R.S. Mansbach, E. Brooks, Y. Chen, Antidepressant-like effects of CP154,526, a selective CRF1 receptor antagonist, Eur. J. Pharmacol. 323 (1997) 21-26.
120. J.R. Mantsch, N.E. Goeders, Ketoconazole blocks the stress-induced reinstatement of cocaine-seeking behavior in rats: relationship to the discriminative stimulus effects of cocaine, Psychopharmacology 142 (1999) 399-407.
121. A. Markou, F. Weiss, L.H. Gold, B. Caine, G. Schulteis, G.F. Koob, Animal models of drug craving, Psychopharmacology 112 (1993) 163-182.
122. C.J. McDougle, J.E. Black, R.T. Malison, R.C. Zimmermann, T.R. Kosten, G.R. Heninger, L.H. Price, Noradrenergic dysregulation during discontinuation of cocaine use in addicts, Arch. Gen. Psychiatry 51 (1994) 713-719.
123. M.E. McFall, P.W. Mackay, D.M. Donovan, Combat-related posttraumatic stress disorder and severity of substance abuse in Vietnam veterans, J. Stud. Alcohol 53 (1992) 357-363.
124. R.C. Meibach, A. Siegel, Efferent connections ofthe septal area in the rat: an analysis utilizing retrograde and anterograde transport methods, Brain Res. 119 (1977) 1-20.
125. W.M. Meil, R.E. See, Conditioned cued recovery of responding following prolonged withdrawal from self-administered cocaine in rats: an animal model of relapse, Behav. Pharmacol. 7 (1996) 754-763.
126. K.R. Melia, C.B. Sananes, M. Davis, Lesions ofthe central nucleus of the amygdala block the excitatory effects of septal ablation on the acoustic startle reflex, Physiol. Behav. 51 (1991) 175-180.
127. R.E. Meyer, S.M. Mirin, in: The Heroin Stimulus: Implications For a Theory of Addiction, Plenum Medical Book Company, New York, 1979.
128. K.A. Miczek, N. Mutchler, Activational effects of social stress on IV cocaine self-administration in rats, Psychopharmacology 128 (1996) 256-264.
129. L. Miller, Predicting relapse and recovery in alcoholism and addiction: neuropsychology, personality, and cognitive style, J. Subst. Abuse Treat. 8 (1991) 277-291.
130. R. Mongeau, P. Blier, C. de Montigny, The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments, Brain Res. Rev. 23 (1997) 145-195.
131. R.Y. Moore, F.E. Bloom, Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems, Annu. Rev. Neurosci. 2 (1979) 113-168.
132. J.E. Morley, A.S. Levine, Stress-induced eating is mediated by endogenous opioid peptides, Science 209 (1980) 1259-1261.
133. J.E. Morley, A.S. Levine, Corticotrophin releasing factor, grooming and ingestive behavior, Life Sci. 31 (1982) 1459-1464.
134. T. Narahashi, Mechanism of action of tetrodotoxin and saxitoxin on excitable membranes, Fed. Proc. 31 (1972) 1124-1132.
135. E.J. Nestler, G.K. Aghajanian, Molecular and cellular basis of addiction, Science 278 (1997) 58-63.
136. M. Numan, A lesion and neuroanatomical tract-tracing analysis of the role of the bed nucleus of the stria terminalis in retrieval behavior and other aspects of maternal responsiveness in rats, Dev. Psychobiol. 29 (1996) 23-51.
137. M. Numan, Projection sites of medial preoptic area and ventral bed nucleus of the stria terminalis neurons that express Fos during maternal behavior in female rats, J. Neuroendocrinol. 9 (1997) 369-384.
138. M. Numan, T. Sheehan, Neuroanatomical circuitry for mammalian maternal behavior, Ann. NY Acad. Sci. 807 (1997) 101-125.
139. C.P. O'Brien, A range of research-based pharmacotherapies for addiction, Science 278 (1997) 66-70.
140. F. O'Doherty, B.J. Davies, Life events and addiction: a critical review, Br. J. Addict. 82 (1987) 127-137.
141. S. Okuyama, S. Chaki, S. Ogawa, A. Nakazato, T. Kumagai, T. Okubo, K. Tomisawa, Receptor binding, behavioral, and electro-physiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001, J. Pharmacol. Exp. Ther. 289 (1999) 926-935.
142. K. Pacak, M. Palkovits, I.J. Kopin, D.S. Goldstein, Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity: in vivo microdialysis studies, Front. Neuroendocrinol. 16 (1998) 89-150.
143. I.P. Pavlov, in: Conditioned Reflexes, Oxford University Press, Oxford, 1927.
144. R. Pechnick, Effects of opioids on the hypothalamo-pituitary-adrenal axis, Annu. Rev. Pharmacol. Toxicol. 32 (1999) 353-383.
145. K.W. Perry, R.W. Fuller, Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum, Life Sci. 50 (1992) 1683-1690.
146. C.F. Phelix, W.K. Paull, Demonstration of distinct corticotropin releasing factor-containing neuron populations in the bed nucleus of the stria terminalis. A light and electron microscopic immuno-cytochemical study in the rat, Histochemistry 94 (1990) 345-364.
147. C.F. Phelix, Z. Liposits, W.K. Paull, Monoamine innervation ofbed nucleus of stria terminalis: an electron microscopic investigation, Brain Res. Bull. 28 (1992) 949-965.
148. C.F. Phelix, Z. Liposits, W.K. Paull, Catecholamine-CRF synaptic interaction in a septal bed nucleus: afferents of neurons in the bed nucleus of the stria terminalis, Brain Res. Bull. 33 (1994) 109119.
149. P.V. Piazza, M. Le Moal, Pathophysiological basis of vulnerability to drug abuse: Interaction between stress, glucocorticoids, and dopaminergic neurons, Annu. Rev. Pharmacol. Toxicol. 36 (1996) 359-378.
150. P.V. Piazza, M. Le Moal, The role of stress in drug self-administration, Trends Pharmacol. Sci. 19 (1998) 67-74.
151. E.M. Pich, M. Lorang, M. Yeganeh, F.R. de Foncesca, J. Raber, G.F. Koob, F. Weiss, Increase of extracellular corticotropin-releas-ing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis, J. Neurosci. 15 (1995) 5439-5447.
152. J.E. Piletz, A. Halaris, P.R. Ernsberger, Psychopharmacology of imidazoline and alpha 2-adrenergic receptors: implications for depression, Crit. Rev. Neurobiol. 9 (1994) 29-66.
153. E. Potter, S. Sutton, C. Donaldson, R. Chen, P. Lewis, P. Sawchenko, W. Vale, Distribution of corticotropinreleasing factor receptor mRNA expression the rat brain and pituitary, Proc. Natl. Acad. Sci. USA 91 (1994) 8777-8781.
154. D.E.J. Redmond, Studies of the nucleus locus coeruleus in monkeys and hypotheses for neuropsychopharmacology, in: H.Y. Meltzer (Ed.), Psychopharmacology: The Third Generation of Progress, Raven Press, New York, 1987, pp. 967-975.
155. D.E.J. Redmond, Y.H. Huang, Locus coeruleus and anxiety, Life Sci. 25 (1979) 2149-2162.
156. D.E.J. Redmond, J.H. Krystal, Multiple mechanisms ofwithdrawal from opioid drugs, Annu. Rev. Neurosci. 7 (1984) 443-478.
157. R.M. Richter, F. Weiss, In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats, Synapse 32 (1999) 254-261.
158. C. Rivier, Alcohol stimulates ACTH secretion in the rat: mechanisms of action and interactions with other stimuli, Alcohol. Clin. Exp. Res. 47 (1996) 1269-1273.
159. T.W. Robbins, P.J. Fray, Stress-induced eating: fact, fiction or misunderstanding, Appetite 1 (1980) 103-133.
160. T.E. Robinson, K.C. Berridge, The neural basis ofdrug craving: an incentive-sensitization theory of addiction, Brain Res. Rev. 18 (1993) 247-291.
161. T.E. Robinson, K.E. Browman, H.S. Crombag, A. Badiani, Modulation of the induction or expression of psychostimulant sensitiza-tion by the circumstances surrounding drug administration, Neuro-sci. Biobehav. Rev. 22 (1998) 347-354.
162. G. Roldan, J. Bures, Tetrodotoxin blockade of amygdala overlapping with poisoning impairs acquisition of conditioned taste aversion in rats, Behav. Brain Res. 65 (1994) 213-219.
163. B.D. Sachs, R.J. Barfield, Copulatory behavior of male rats given intermittent electric shocks: theoretical implications, J. Comp. Physiol. Psychol. 86 (1974) 607-615.
164. B.J. Sahakian, T.W. Robbins, R.J. Deeley, B.J. Everitt, L.T. Dunn, M. Wallace, W.P.T. James, Changes in body weight and food-related behaviour induced by destruction of the ventral or dorsal noradrenergic bundle in the rat, Neuroscience 10 (1983) 1405-1420.
165. M. Sakanaka, T. Shibasaki, K. Lederis, Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex, Brain Res. 382 (1986) 213-238.
166. Z. Sarnyai, Neurobiology of stress and cocaine addiction. Studies on corticotropin-releasing factor in rats, monkeys, and humans, Annal. NY Acad. Sci. 851 (1998) 371-387.
167. Z. Sarnyai, E. Biro, J. Gardi, M. Vecsernyes, J. Julesz, G. Telegdy, Brain corticotropin-releasing factor mediates 'Anxiety-like' behavior induced by cocaine withdrawal in rats, Brain Res. 657 (1995) 89-97.
168. Z. Sarnyai, F.S. Dhabhar, B.S. McEwen, M.J. Kreek, Neuroendocrine-related effects of long-term, 'binge' cocaine administration: diminished individual differences in stress-induced corticos-terone response, Neuroendocrinology 68 (1998) 334-344.
169. J. Schulkin, P.W. Gold, B.S. McEwen, Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load, Psychoneuroendocrinology 23 (1998) 219-243.
170. D.W. Schulz, R.S. Mansbach, J. Sprouse, J.P. Braselton, J. Collins, M. Corman, A. Dunaiskis, S. Faraci, A.W. Schmidt, T. Seeger, P. Seymour, D.F.I. Tingley, E.N. Winston, Y.L. Chen, J. Heym, CP154,526: a potent and selective non-peptide antagonist of corticotropin releasing factor receptors, Proc. Natl. Acad. Sci. USA 93 (1996) 10477-10482.
171. A. Scriabine, C.S. Sweet, C.T. Ludde, J.M. Stavorski, H.C. Wenger, N.R. Bohidar, Some cardiovascular effects of ST-91 and clonidine, Eur. J. Pharmacol. 43 (1975) 333-341.
172. D.W. Self, E.J. Nestler, Relapse to drug-seeking: neural and molecular mechanisms, Drug Alcohol Depend. 51 (1998) 49-69.
173. D.W. Self, W.J. Barnhart, D.A. Lehman, E.J. Nestler, Opposite modulation of cocaine-seeking behavior by D1and D2-like dopamine receptor agonists, Science 271 (1996) 1586-1589.
174. D.W. Self, L.M. Genova, B.T. Hope, W.J. Barnhart, J.J. Spencer, E.J. Nestler, Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine selfadministration and relapse of cocaine-seeking behavior, J. Neurosci. 18 (1998) 1848-1859.
175. H. Selye, in: The Stress of Life, McGraw-Hill, New York, 1956.
176. Y. Shaham, Immobilization of stress-induced oral opioid self-administration and withdrawal in rats: Role of conditioning factors and the effect of stress on 'relapse' to opioid drugs, Psychopharmacology 111 (1993) 477-485.
177. Y. Shaham, Effect of stress on opioid-seeking behavior: evidence from studies with rats, Ann. Behav. Med. 18 (1996) 255-263.
178. Y. Shaham, J. Stewart, Stress reinstates heroin self-administration behavior in drug-free animals: an effect mimicking heroin, not withdrawal, Psychopharmacology 119 (1995) 334-341.
179. Y. Shaham, J. Stewart, Effects of opioid and dopamine receptor antagonists on relapse induced by stress and reexposure to heroin in rats, Psychopharmacology 125 (1996) 385-391.
180. Y. Shaham, H. Rajabi, J. Stewart, Relapse to heroin-seeking under opioid maintenance: the effects of opioid withdrawal, heroin priming and stress, J. Neurosci. 16 (1996) 1957-1963.
181. Y. Shaham, L.K. Adamson, S. Grocki, W.A. Corrigall, Reinstatement and spontaneous recovery of nicotine-seeking in rats, Psychopharmacology 130 (1997) 396-403.
182. Y. Shaham, D. Funk, S. Erb, T.J. Brown, C.D. Walker, J. Stewart, Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats, J. Neurosci. 17 (1997) 2605-2614.
183. Y. Shaham, J. Puddicombe, J. Stewart, Sexually arousing events do not induce relapse to heroin-seeking in sexually experienced male rats, Physiol. Behav. 61 (1997) 337-341.
184. Y. Shaham, S. Erb, S. Leung, Y. Buczek, J. Stewart, CP-154,526, a selective, non peptide antagonist of the corticotropin-releasing factor type 1 receptor attenuates stress-induced relapse to drug seeking in cocaine-and heroin-trained rats, Psychopharmacology 137 (1998) 184-190.
185. Y. Shaham, D. Highfield, J.M. Delfs, S. Leung, J. Stewart, Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of the locus coeruleus noradrenergic neurons, Eur. J. Neurosci. 12 (2000) 292-302.
186. M. Shaikh, M. Brutus, H. Siegel, A. Siegel, Regulation of feline aggression by the bed nucleus of stria terminalis, Brain Res. Bull. 16 (1986) 179-182.
187. U. Shalev, D. Highfield, J. Yap, Y. Shaham, Stress and relapse to drug
188. U. Shalev, B. Hope, A. Clements, D. Highfield, M. Morales, Y. Shaham, Stress-induced relapse to heroin seeking after different drug-free periods, Soc. Neurosci. Abstr. 25 (1999) 1572.
189. S. Shiffman, T.A. Wills, in: Coping and Substance Abuse, Academic Press, Orlando, FL, 1985.
190. S. Siegel, Pharmacological conditioning and drug effects, in: A.J. Goudie, M.W. Emmett-Oglesby (Eds.), Psychoactive Drug Tolerance and Sensitization, Humana Press, Clifton, NJ, 1989, pp. 115-180.
191. R. Sinha, D. Catapano, S. O'Mally, Stress-induced craving and stress responses in cocaine dependent individuals, Psychopharmacology 142 (1999) 343-351.
192. H.M. Sinnamon, Microstimulation mapping of the basal forebrain in the anesthetized rat: the 'preoptic locomotor response', Neuroscience 50 (1992) 197-207.
193. N. Sonino, The use of ketoconazole as an inhibitor of steroid production, New Engl. J. Med. 317 (1987) 812-818.
194. R.D. Spealman, R.L. Barrett-Larimore, J.K. Rowlett, D.M. Platt, T.V. Khroyan, Pharmacological and environmental determinants of relapse to cocaine-seeking behavior, Pharmacol. Biochem. Behav. 64 (1999) 327-336.
195. S.C. Stanford, Central noradrenergic neurones and stress, Pharmacol. Ther. 68 (1995) 297-342.
196. B.G. Stanley, VL.3. Willett, H.W. Donias, M.G.2. Dee, M.A. Duva, Lateral hypothalamic NMDA receptors and glutamate as physiological mediators of eating and weight control, Am. J. Physiol. 270 (1996) R443-R449.
197. J. Stewart, Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area, Pharmacol. Biochem. Behav. 20 (1984) 917-923.
198. J. Stewart, Neurobiology of conditioning to abuse, Ann. NY Acad. Sci. 654 (1992) 335-346.
199. J. Stewart, H. de Wit, Reinstatement of drug-taking behavior as a method of assessing incentive motivational properties of drugs, in: M.A. Bozarth (Ed.), Methods of Assessing the Reinforcing Properties of Abused Drugs, Springer, New York, 1987, pp. 211-227.
200. J. Stewart, R. Eikelboom, Conditioned drug effects, in: L.L. Iversen, S.D. Iversen, S.H. Snyder (Eds.), Handbook of Psycho-pharmacology, Plenum, New York, 1987, pp. 1-57.
201. J. Stewart, P. Vezina, A comparison of the effects of intra-accum-bens injections of amphetamine and morphine on reinstatement of heroin intravenous self-administration behavior, Brain Res. 457 (1988) 287-294.
202. J. Stewart, R.A. Wise, Reinstatement of heroin self-administration habits: morphine prompts and naltrexone discourages renewed responding after extinction, Psychopharmacology 108 (1992) 7984.
203. J. Stewart, H. de Wit, R. Eikelboom, Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants, Psychol. Rev. 91 (1984) 251-268.
204. V. Strbak, J. Benicky, L. Macho, D. Jezova, M. Nikodemova, Four-week ethanol intake decreases food intake and body weight but does not affect plasma leptin, corticosterone, and insulin levels in pubertal rats, Metabolism 47 (1998) 1269-1273.
205. R. Stretch, G.J. Gerber, S.M. Wood, Factors affecting behavior maintained by response-contingent intravenous infusions of amphetamine in squirrel monkeys, Can. J. Physiol. Pharmacol. 49 (1971) 581-589.
206. M.A. Sutton, D.A. Karanian, D.W. Self, Factors that determine a propensity for relapse to cocaine-seeking behavior in rats, Neuropsychopharmacology 22 (2000) 626-641.
207. M. Tanaka, A. Tsuda, H. Yokoo, M. Yoshida, I. Yoshishige, H. Nishimura, Involvement of the brain noradrenaline system in emotional changes caused by stress in rats, Annal. NY Acad. Sci. 597 (1990) 159-174.
208. M. Terenzi, C. Ingram, A combined immunocytochemical and retrograde tracing study of noradrenergic connections between the caudal medulla and bed nuclei of the stria terminalis, Brain Res. 672 (1995) 289-297.
209. G.W. Terman, Y. Shavit, J.W. Lewis, J.T. Cannon, J.C. Liebeskind, Intrinsic mechanisms of pain inhibition: activation by stress, Science 220 (1984) 1270-1277.
210. G. Torres, C. Rivier, Differential effects of intermittent or continuous exposure to cocaine on the hypothalamic-pituitary-adrenal axis and c-fos expression, Brain Res. 571 (1992) 204-211.
211. T.L. Tran-Nguyen, R.A. Fuchs, G.P. Coffey, L.E. O'Dell, D.A. Baker, J.L. Neisewander, Time-dependent changes in cocaine-seeking behavior and dopamine overflow in the amygdala during cocaine withdrawal, Neuropsychopharmacology 19 (1998) 48-59.
212. W. Vale, J. Spiess, C. Rivier, J. Rivier, Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin, Science 213 (1981) 1394-1397.
213. D. Van der Kooy, K. Nader, Deprivation state switches the neurobiological substrates mediating opiate reward in the ventral tegmental area, J. Neurosci. 17 (1997) 383-390.
214. P. Veinante, M.E. Stoeckel, M.J. Freund-Mercier, GABA- and peptide-immunoreactivities co-localize in the rat central extended amygdala, Neuroreport 8 (1997) 2985-2989.
215. E.A. Warner, T.R. Kosten, P.G. O'Connor, Pharmacotherapy for opioid and cocaine abuse, Med. Clin. North Am. 81 (1997) 909-925.
216. K.L. Weller, D.A. Smith, Afferent connections of the bed nucleus of the stria terminalis, Brain Res. 232 (1982) 255-270.
217. C.C. Whitehead, Methadone pseudowithdrawal syndrome: paradigm for a psychopharmacological model of opiate addiction, Psychosom. Med. 36 (1974) 189-198.
218. R.A. Wise, Neurobiology of addiction, Curr. Opin. Neurobiol. 6 (1996) 243-251.
219. R.A. Wise, M.A. Bozarth, A psychomotor stimulant theory of addiction, Psychol. Rev. 94 (1987) 469-492.
220. R.A. Wise, P.P. Rompre, Brain dopamine and reward, Annu. Rev. Psychol. 40 (1989) 191-225.
221. R.A. Wise, A. Murray, M.A. Bozarth, Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats, Psychopharmacology 100 (1990) 355-360.
222. Y. Zhou, R. Spangler, K. LaForge, C. Maggos, A. Ho, M.J. Kreek, Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during 'binge'-pattern cocaine administration and chronic withdrawal, J. Pharmacol. Exp. Ther. 279 (1996) 351-358.